New patent for Gilead Sciences drug SUNLENCA April 25, 2024 AutoBot News 0 Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are four… Source